Clasificación en acciones
#13334
Sensorion SA, a clinical-stage biopharmaceutical company, develops drug... Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.
Precio por acción
$0.30543496
Capitalización bursátil
$93.46M
Comercio Sensorion SA (ALSEN)
Precio ALSEN con Capital del mercado a B
Capitalización de mercado de Sensorion SA(ALSEN)
Capitalización bursátil: $93.46M
A fecha de July 2026, Sensorion SA tiene una capitalización de mercado de $93.46M. Esto convierte a Sensorion SA en la 13334th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Sensorion SA desde 2015 hasta 2026
ALSEN en comparación con los más populares 5 títulos stocks
| Precio por ALSEN |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.110T
|
+5,466,937.08%
|
|
|
|
|
$4.631T
|
+4,955,029.08%
|
|
|
|
|
$4.320T
|
+4,622,094.12%
|
|
|
|
|
$2.861T
|
+3,060,667.82%
|
|
|
|
|
$2.639T
|
+2,823,631.51%
|
